Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Expert Opinion on Pharmacotherapy|March 23, 2019
Tadalafil for the treatment of benign prostatic hyperplasiaFabiola Zakia Mónica, Gilberto De Nucci
Biochemical Pharmacology|September 29, 2022
Endothelial and vascular smooth muscle dysfunction in hypertensionMariana Gonçalves de Oliveira, Wilson Nadruz, Fabiola Zakia Mónica
European Journal of Pharmacology|April 15, 2018
Mirabegron, a β3-adrenoceptor agonist reduced platelet aggregation through cyclic adenosine monophosphate accumulationCamila Bitencourt Mendes-Silvério, Evandro Marcos Alexandre, Caroline Honaiser Lescano, et al.
Frontiers in Pharmacology|March 1, 2021
The Role of Periprostatic Adipose Tissue on Prostate Function in Vascular-Related DisordersGabriela Reolon Passos, Ana Carolina Ghezzi, Edson Antunes, et al.
Life Sciences|July 2, 2023
Agomelatine inhibits platelet aggregation through melatonin receptor-dependent and independent mechanismsJulia Modesto Vicente, Caroline Honaiser Lescano, Silvana Bordin, et al.
Cancers|March 11, 2023
Soluble Guanylate Cyclase β1 Subunit Represses Human Glioblastoma GrowthHaijie Xiao, Haifeng Zhu, Oliver Bögler, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|June 10, 2016
Epigenetic regulation of soluble guanylate cyclase (sGC) β1 in breast cancer cellsAlex Sotolongo, Fabiola Zakia Mónica, Alex Kots, et al.
Antioxidants (Basel, Switzerland)|July 29, 2025
The RAGE Inhibitor TTP488 (Azeliragon) Improves Diabetic Bladder Dysfunction in Leptin-Deficient Obese MiceAkila Lara Oliveira, Matheus Leite Medeiros, Antonio Thiago Pereira Campos, et al.
European Journal of Pharmacology|July 30, 2026
Probenecid enhances relaxation induced by cyclic adenosine monophosphate- and cyclic guanosine monophosphate-augmenting substances in rat prostate, bladder, and corpus cavernosum: a potential repurposing strategyGuilherme Ruiz Leonardi, Mariana Burille Moretti, João Correa, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 16, 2018
Inhibition of Multidrug Resistance Proteins by MK 571 Enhances Bladder, Prostate, and Urethra Relaxation through cAMP or cGMP AccumulationGabriela Maria Bertollotto, Mariana Gonçalves de Oliveira, Eduardo Costa Alexandre, et al.
Pageof 2